Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ester Vanni

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|November 30, 2006
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosisElisabetta Bugianesi, Gulio Marchesini, Elena Gentilcore, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2014
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver diseaseSalvatore Petta, Ester Vanni, Elisabetta Bugianesi, et al.
The American Journal of Gastroenterology|March 30, 2007
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control studyLuca Valenti, Anna Ludovica Fracanzani, Paola Dongiovanni, et al.
The American Journal of Gastroenterology|April 22, 2005
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver diseaseElisabetta Bugianesi, Elena Gentilcore, Rita Manini, et al.
Diabetes Research and Clinical Practice|January 24, 2004
Non-alcoholic steatohepatitis in patients cared in metabolic unitsGiulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, et al.
Hepatology (Baltimore, Md.)|January 31, 2004
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liverElisabetta Bugianesi, Paola Manzini, Sergio D'Antico, et al.
Hepatology (Baltimore, Md.)|April 2, 2003
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeGiulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, et al.
Hepatology (Baltimore, Md.)|August 30, 2008
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetesAnna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi, et al.
Gastroenterology|July 10, 2002
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinomaElisabetta Bugianesi, Nicola Leone, Ester Vanni, et al.
Journal of Hepatology|December 15, 2010
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposityAnna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|November 30, 2006
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosisElisabetta Bugianesi, Gulio Marchesini, Elena Gentilcore, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2014
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver diseaseSalvatore Petta, Ester Vanni, Elisabetta Bugianesi, et al.
The American Journal of Gastroenterology|March 30, 2007
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control studyLuca Valenti, Anna Ludovica Fracanzani, Paola Dongiovanni, et al.
The American Journal of Gastroenterology|April 22, 2005
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver diseaseElisabetta Bugianesi, Elena Gentilcore, Rita Manini, et al.
Diabetes Research and Clinical Practice|January 24, 2004
Non-alcoholic steatohepatitis in patients cared in metabolic unitsGiulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, et al.
Hepatology (Baltimore, Md.)|January 31, 2004
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liverElisabetta Bugianesi, Paola Manzini, Sergio D'Antico, et al.
Hepatology (Baltimore, Md.)|April 2, 2003
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeGiulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, et al.
Hepatology (Baltimore, Md.)|August 30, 2008
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetesAnna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi, et al.
Gastroenterology|July 10, 2002
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinomaElisabetta Bugianesi, Nicola Leone, Ester Vanni, et al.
Journal of Hepatology|December 15, 2010
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposityAnna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi, et al.
Pageof 5